5 Key Takeaways

• 1

  Glaucoma is often mismanaged, with 90% of patients failing to adhere to prescribed drop therapy, leading to disease progression and vision loss.

• 2

  Interventional glaucoma approaches can improve patient quality of life by stabilizing intraocular pressure and delaying disease progression.

• 3

  Topical medications are effective but often used as a bridge therapy due to high rates of nonadherence and side effects.

• 4

  Minimally invasive glaucoma surgery (MIGS) offers safer options for early intervention compared to traditional surgical methods.

• 5

  The LiGHT trial shows early selective laser trabeculoplasty can achieve better IOP control and reduce medication dependence over time.